Relationship between baseline severity of depression and antidepressant treatment outcome

Pharmacopsychiatry

Volumn 44, Issue 1, 2011, Pages 27-32

  Henkel, V ^a   Seemuller F ^a   Obermeier, M ^a   Adli, M ^b   Bauer, M ^c   Kronmuller K ^d   Holsboer, F ^e   Brieger, P ^f   Laux, G ^g   Bender, W ^h   Heuser, I ^b   Zeiler, J ⁱ   Gaebel, W ^j   Mayr, A ^a   Riedel, M ^a   Moller H J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^f MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^g Inn Salzach Klinikum   (Germany)

^h KLINIKUM MÜNCHEN OST   (Germany)

ⁱ Vivantes Auguste Viktoria Klinikum   (Germany)

^j HEINRICH HEINE UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BROMAZEPAM; CITALOPRAM; DIAZEPAM; DOXEPIN; HYPNOTIC AGENT; LORAZEPAM; MIRTAZAPINE; NEUROLEPTIC AGENT; OXAZEPAM; PAROXETINE; REBOXETINE; SERTRALINE; TRANQUILIZER; TRANYLCYPROMINE; TRIMIPRAMINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME;

EID: 79551550386     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0030-1267177     Document Type: Article

References (34)

1. th edition, Text Revision) Washington, DC. 2000
2. Bagby RM, Ryder AG, Schuller DR, et al. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 2004 161 2163-2177
3. Bauer M, Bschor T, Pfennig A, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007 8 67-104
4. Cording C, Gaebel W, Spengler A. Die neue psychiatrische Basisdokumentation. Eine Empfehlung der DGPPN zur Qualit tssicherung im (teil-) station ren Bereich. [The new psychiatric basic documentation. A recommendation by the DGPPN for quality assurance in inpatient treatment]. Spektrum Psychiatrie Nervenheilkunde 1995 3-41
5. Coyne JC, Fechner-Bates S, Schwenk TL. Prevalence, nature, and comorbidity of depressive disorders in primary care. Gen Hosp Psychiatry 1994 16 267-276
6. CPMP. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on clinical investigation of medicinal products in the treatment of depression. CPMP/EWP/518/97 Rev.1. 1997
7. Elkin I, Shea MT, Watkins JT, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program General effectiveness of treatments. Arch Gen Psychiatry 1989 46 971-982
8. Guy W. Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology. National Institute of Mental Health, Rockville, MD revised 1976
9. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967 6 278-296
10. Hegerl U, Hautzinger M, Mergl R, et al. Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm. Int J Neuropsychopharmacol 2010 13 31-44
11. Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998 55 694-700
12. Judd LL, Rapaport MH, Yonkers KA, et al. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Am J Psychiatry 2004 161 1864-1871
13. Kessler RC, Zhao S, Blazer DG, et al. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord 1997 45 19-30
14. Khan A, Schwartz K, Kolts RL, et al. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes. Biol Psychiatry 2007 62 65-71
15. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008 5 e45
16. Lyness JM, Heo M, Datto CJ, et al. Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med 2006 144 496-504
17. Markowitz JC. Psychotherapy of dysthymia. Am J Psychiatry 1994 151 1114-1121
18. Melander H, Salmonson T, Abadie E, et al. A regulatory Apologia - a review of placebo-controlled studies in regulatory submissions of new-generation antidepressants. Eur Neuropsychopharmacol 2008 18 623-627
19. Moller HJ. Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008. Eur Arch Psychiatry Clin Neurosci 2008 258 451-455
20. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979 134 382-389
21. Morris JB, Beck AT. The efficacy of antidepressant drugs. A review of research (1958-1972). Arch Gen Psychiatry 1974 30 667-674
22. Mulrow CD, Williams JW Jr, Chiquette E, et al. Efficacy of newer medications for treating depression in primary care patients. Am J Med 2000 108 54-64
23. Paykel ES, Freeling P, Hollyman JA. Are tricyclic antidepressants useful for mild depression? A placebo controlled trial. Pharmacopsychiatry 1988 21 15-18
24. Rapaport MH, Judd LL, Schettler PJ, et al. A descriptive analysis of minor depression. Am J Psychiatry 2002 159 637-643
25. Rush AJ, First MB, Blacker D. Handbook of Psychiatric Measures, Edition Number: 2 edn.,. 2007
26. Sartorius N, Ustun TB, Lecrubier Y, et al. Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl 1996 38-43
27. Schulberg HC, Block MR, Madonia MJ, et al. Treating major depression in primary care practice Eight-month clinical outcomes. Arch Gen Psychiatry 1996 53 913-919
28. Seemuller F, Riedel M, Obermeier M, et al. Outcomes of 1014 naturalistically treated inpatients with major depressive episode. Eur Neuropsychopharmacol 2010
29. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008 358 252-260
30. Wagner HR, Burns BJ, Broadhead WE, et al. Minor depression in family practice: functional morbidity, co-morbidity, service utilization and outcomes. Psychol Med 2000 30 1377-1390
31. Wilcox CS, Cohn JB, Linden RD, et al. Predictors of placebo response: a retrospective analysis. Psychopharmacol Bull 1992 28 157-162
32. Williams JW Jr, Barrett J, Oxman T, et al. Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults. JAMA 2000 284 1519-1526
33. Wittchen HU, Wunderlich U, Gruschwitz S, et al. Strukturiertes Klinisches Interview f r DSM-IV G ttingen, Hogrefe. 1997
34. World Health Organization. The ICD-10 Classification of Mental and behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva, WHO 1992